Markers for Blood-Based Diagnosis of Blindness-Related Major Eye Disease and Method for Diagnosis Using the Same

摘要

The present invention relates to a blood marker for diagnosing major eye diseases causing blindness and a diagnostic method using the same, and more particularly, to age related macular degeneration (AMD), diabetic retinopathy, cataract and The present invention relates to a marker for diagnosing one or more blindness-causing eye diseases selected from the group consisting of glaucoma, and a composition, kit, and method for diagnosing blindness-causing eye diseases using the same. The marker for diagnosing blindness-induced eye disease, a diagnostic composition, a diagnostic kit, or a method of providing information necessary for diagnosis of the present invention is a new immunological diagnostic tool using the patient's plasma, which has excellent sensitivity and is capable of generating plasma without using a biopsy. In addition to being able to easily analyze the target, it was confirmed that high diagnostic ability was obtained by combining the protein quantitative value of the diagnostic marker and basic clinical information and analyzing it, so it can be usefully used for the diagnosis of blindness-causing eye diseases.